Attendee search 

Mercadyne Advisors LLC advises private and public companies regarding capital strategy, business strategy, board governance, and restructuring. 

Mercadyne enables public companies to maximize shareholder value by positioning the company’s capitalization, Board and enterprise such that Wall Street will reward them for their business. 

Mercadyne also provides private companies seeking capital and liquidity an alternative financing path to the conventional, strict venture capital-to-large IPO process. We provide these emerging growth companies with an alternative public offering (APO) or direct public offering (DPO), structure via a public vehicle or small IPO (SIPO) strategy.

We work with like-minded highly innovative people to develop meaningful medicines and create impactful health care solutions.

We are:

• - Provide comprehensive scientific, strategic, and regulatory support to plan, manage, and execute full development programs  
• - Formulate early development, clinical pharmacology and translational medicine strategies to fast-track preclinical development to POC
• - Improve decision making with an emphasis on quantitative analytics and use of modeling and simulation
• - Provide a fully capable and experienced drug development team, or individual components based on client needs

The New York Stem Cell Foundation (NYSCF) is a non-profit organization whose mission is to accelerate stem cell research to cure the major diseases of our time. Our programs are focused in three areas: 

• Directing critical, advanced stem cell research in its own laboratory and also supports advanced work in other leading institutions. 

• Developing the next generation of top stem cell scientists by training and supporting an elite group of post-doctoral research fellows. 

• Convening the preeminent annual translation stem cell research conference and an on-going series of programs for scientists, policymakers and the public.

Medical Research, Events, Research Funding

Biomedical research is gravitating towards 3D cell culture models and tissue printing. At n3D, we sell kits and services for 3D cell culture. Our core technology is the magnetization of cells, which can then be directed using magnetic forces. In this manner, we can either levitate or bioprint cells. These cultures are faster to assemble than other systems and easier to handle with magnets without losing samples. Check out our products and ourservices for more information on our technology, and how we can help you!

At Precision for Medicine, we specialize in accelerating the development, approval and launch of complex or first-in-class medical technologies.  We work regularly with medical device, diagnostics and life sciences companies as well as with investors in this space.  We have expert teams in each of regulatory affairs, biostatistics and analytics, clinical trial services, commercial strategy and market access/reimbursement.  Our experts work within and across these verticals to develop the latest techniques for product success.  

Core services include:

To-Market Strategy, a collaborative effort to manage risk and maximize opportunity at each stage of product development 

Due Diligence and Opportunity Assessments, to inform potential investments or new areas of product development

Regulatory Strategy and Support, including U.S. FDA, E.U. and global regulatory stratgies, negotitations and submissions

Evidence Development Strategy, including advanced non-clinical and clinical trial designs, statistical analysis plans, and literature-based approaches

Clinical Trial Services, from study start through conclusion and reporting

KOL Recruitment and management of key clinical advisors (CABs, SABs, KOLs, expert panels and reports, study investigators, etc.)

Market Access Services, including payer communications, reimbursement strategy, and health economics

Personalized Medicine Strategies, including responder analyses, companion diagnostics and biomarker identification 

Digital Medicine Strategy, including software-based products and accessory apps

Business Strategy, including business model ideation, market research, due diligence and fundraising support

AzurRx BioPharma aims to become a leader in developing non-systemic, recombinant protein therapies for the treatment of gastrointestinal diseases and related conditions. MS1819 recombinant lipase for exocrine pancreatic insufficiency is the lead development program with additional early stage research being conducted for the prevention of hospital-acquired infection. AzurRx BioPharma, Inc. is a recently founded private biotechnology company formed to focus on the development of the early stage pharmaceutical assets of ProteaBio Europe. The company is headquartered in New York, NY, with scientific operations based in Langlade, France.

OPKO Health, Inc. is a multi-national pharmaceutical and diagnostics company that aims to establish industry-leading positions in large and rapidly growing medical markets by leveraging our discovery, development, and commercialization expertise and our novel and proprietary technologies. We intend to leverage our global commercialization expertise to pursue acquisitions of commercial businesses that will both drive our growth and provide geographically diverse sales and distribution opportunities. We have and may continue to make investments in other early stage companies that we perceive to have valuable proprietary technology and significant potential to create value for OPKO as a shareholder. 

Our Focus is on Point-of-Care and Novel Molecular Diagnostics, Proprietary Pharmaceuticals, and Vaccines. Since 2009, OPKO has completed five national and international acquisitions contributing to its technology and commercial operations. 

OPKO continues to explore acquisition opportunities for complementary pharmaceuticals, compounds, technologies, and businesses. We expect our future growth to arise from leveraging our proprietary technology, development strengths, and pursuit of complementary and strategic acquisitions and investments.

Pharmaceutical and Diagnostic Products, Medical Devices

Masonic Medical Research Laboratory is a not-for-profit institute dedicated to improving the health and quality of life for all. The Laboratory's primary mission is to conduct high quality basic and clinical research aimed at generating knowledge and information necessary for development of medical cures and treatments of tomorrow. The Laboratory is also committed to providing education and training to basic scientists, clinical researchers and students who will perpetuate and extend the fight against disease.

The Laboratory's primary focus is on basic medical research in the fields of Experimental Cardiology, Cardiac Electrophysiology, Molecular Biology and Molecular Genetics.